In a move that underscores the growing importance of digital transformation in the healthcare sector, Doceree, the global network dedicated solely to physician-only platforms for programmatic messaging, has successfully secured a whopping $35 million in its Series B funding round. This monumental investment was spearheaded by Creaegis, a renowned digital and technology investment firm. Notably, existing investors, including the likes of Eight Roads Ventures and F-Prime Capital, also marked their participation, further bolstering the confidence in Doceree’s vision and capabilities.
The primary objective behind this capital infusion is multifaceted. Firstly, it aims to expedite the development of products and technology. Secondly, it seeks to bolster Doceree’s expansion efforts, ensuring that communications to healthcare professionals (HCPs) are reshaped and optimised across the globe. Such a move is pivotal because effective communication with HCPs can significantly influence patient health outcomes.
Established in 2019, Doceree has been at the forefront of empowering pharmaceutical and life-sciences companies and healthcare media agencies. Their solutions connect with HCPs within their digital workflows seamlessly. This ensures that the messaging is precise and enhances the overall patient health outcomes. With its expansive global network dedicated solely to HCPs, Doceree has made commendable progress in HCP communications. Their programmatic messaging capabilities stand out, assisting clients worldwide in enhancing the efficacy of their physician engagement initiatives.
Harshit Jain MD, the Founder and Global CEO of Doceree, expressed his enthusiasm and vision for the company. He highlighted how Doceree’s pioneering HCP messaging solutions have disrupted the market. Their innovative products have made waves in mature markets like the US and garnered attention in other regions. The company’s unique AI-enabled proprietary technology has simplified HCP engagement on a global scale. Their end-to-end HCP-targeting solutions have been instrumental in ensuring their clients achieve profitable growth. The rapid evolution of the pharma messaging space necessitates solutions that are in sync with the immediate needs of the life sciences industry. The recent investment is a testament to the immense value Doceree is adding to this domain.
Over the past year, Doceree has witnessed exponential growth, with its monthly revenue surging fivefold since its Series A funding in April 2022. The company has been instrumental in introducing pioneering innovations on both the demand and supply sides. This includes the launch of Doceree Enterprise, a global Demand Side Platform (DSP) centred around HCPs, and Doceree Provider, which empowers HCPs to enhance the health outcomes of their patients. Their HCP marketing ecosystem comprises tailor-made solutions that equip life science marketers to engage with physicians at the right moments, ensuring that the messaging is contextually relevant.
Following the overwhelming response to its solutions in markets such as the US, India, and Europe, Doceree has expanded its reach to Africa, Southeast Asia (SEA), and the Gulf Cooperation Council (GCC). Their technology platform has been pivotal in enabling biopharmaceutical companies to establish unparalleled connections with physicians. The company’s growth trajectory is a reflection of its unique, data-driven approach, ensuring communication is both precise and relevant.
In the coming months, Doceree is poised to launch a series of innovative solutions that promise to bring about transformative changes to the global ecosystem. These products are designed to enhance HCP targeting, enriching communications at multiple touchpoints in physicians’ professional and clinical journeys.
The recent funding secured by Doceree underscores a broader trend in the healthcare sector. The increasing reliance on digital platforms to enhance communication and engagement with healthcare professionals. The need for precise, targeted, and effective communication tools becomes paramount as the healthcare landscape becomes more complex. Doceree’s focus on programmatic messaging for HCPs is not just innovative but essential in today’s digital age. Their rapid growth and the confidence shown by investors signal a promising future for digital solutions in healthcare marketing. It will be intriguing to see how Doceree leverages this funding to further its mission and set new benchmarks in the industry.
